Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.41 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 3/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17491336 | 1.00 | ESR1 (0.49) | ESR1GAAKMT2ADGKACNR2 | |
| SCHEMBL17491367 | 1.00 | ESR1 (0.49) | ESR1GAAKMT2ADGKACNR2 | |
| SCHEMBL284525 | 1.00 | ESR1 (0.49) | ESR1GAAKMT2ADGKACNR2 | |
| SCHEMBL283818 | 1.00 | ESR1 (0.49) | ESR1GAAKMT2ADGKACNR2 | |
| SCHEMBL17491170 | 1.00 | ESR1 (0.49) | ESR1GAAKMT2ADGKACNR2 | |
| SCHEMBL17491358 | 1.00 | ESR1 (0.49) | ESR1GAAKMT2ADGKACNR2 | |
| SCHEMBL283674 | 1.00 | ESR1 (0.49) | ESR1GAAKMT2ADGKACNR2 | |
| SCHEMBL667600 | 1.00 | ESR1 (0.49) | ESR1GAAKMT2ADGKACNR2 | |
| SCHEMBL284545 | 1.00 | ESR1 (0.49) | ESR1GAAKMT2ADGKACNR2 | |
| SCHEMBL283571 | 1.00 | ESR1 (0.49) | ESR1GAAKMT2ADGKACNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3137540-B1 | STABILIZING COMPOSITIONS FOR STABILIZING MATERIALS AGAINST ULTRAVIOLET LIGHT AND THERMAL DEGRADATION | CYTEC IND INC (US) | 2024-10-30 | — | — | EP | claimed |
| CN-116745353-A | Compositions and methods for protecting organic polymeric materials from the deleterious effects of UV-C light exposure | 塞特工业公司 | 2023-09-12 | — | — | CN | claimed |
| CN-112912442-B | Copolyetherester formulation with improved thermal stability | 杜邦聚合物公司 | 2023-06-20 | — | — | CN | claimed |
| EP-2864310-B1 | STABILIZER COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND METHODS OF USE | CYTEC TECH CORP (US) | 2022-10-26 | — | — | EP | claimed |
| US-20220212375-A1 | POLYMERIC HOLLOW ARTICLES CONTAINING CHROMAN-BASED COMPOUNDS AND MADE BY ROTATIONAL MOLDING | CYTEC TECHNOLOGY CORP. | 2022-07-07 | — | — | US | claimed |
| US-20220153959-A1 | POLYOLEFIN COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND MOLDED ARTICLES PRODUCED THEREFROM | CYTEC TECHNOLOGY CORP. | 2022-05-19 | — | — | US | claimed |
| CN-114085468-A | Solvent-resistant ABS composite material suitable for blow molding and preparation method thereof | 安徽江淮汽车集团股份有限公司 | 2022-02-25 | — | — | CN | claimed |
| US-10975278-B2 | Granular stabilizer compositions for use in polymer resins and methods of making same | CYTEC INDUSTRIES INC. (US) | 2021-04-13 | — | — | US | claimed |
| EP-2652014-B1 | PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING | CYTEC TECH CORP (US) | 2020-07-01 | — | — | EP | claimed |
| US-10407563-B2 | Processes for producing molded articles stabilized against ultraviolet light and thermal degradation | CYTEC INDUSTRIES INC. (US) | 2019-09-10 | — | — | US | claimed |
| WO-2013188490-A1 | STABILIZER COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND METHODS OF USE | CYTEC TECHNOLOGY CORP. (US) | 2013-12-19 | — | — | WO | claimed |
| US-8501846-B2 | Stabilizer compositions | CYTEC TECHNOLOGY CORP. (US) | 2013-08-06 | — | — | US | claimed |
| US-20130145962-A1 | Stabilizer Compositions Containing Substituted Chroman Compounds and Methods of Use | CYTEC TECHNOLOGY CORP. (US) | 2013-06-13 | — | — | US | claimed |
| US-20120146257-A1 | PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING | CYTEC TECHNOLOGY CORP. (US) | 2012-06-14 | — | — | US | claimed |
| US-20100256266-A1 | STABILIZER COMPOSITIONS | CYTEC TECHNOLOGY CORP. (US) | 2010-10-07 | — | — | US | claimed |
| US-7759417-B2 | Stabilizer compositions | CYTEC TECHNOLOGY CORP. (US) | 2010-07-20 | — | — | US | claimed |
| US-20090149581-A1 | STABILIZER COMPOSITIONS | CYTEC TECHNOLOGY CORP. (US) | 2009-06-11 | — | — | US | claimed |
| US-5081170-A | Polyolefin, phenolic antioxidant, light stabilizer, sulfur antioxidant, talc filler, weatherproofing | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1992-01-14 | — | — | US | claimed |
| EP-0069702-B1 | STOP CHAIN AGENT FOR VINYLCHLORIDE POLYMERISATION | CIBA-GEIGY AG (CH) | 1985-06-05 | — | — | EP | claimed |
| EP-0069702-A2 | Stop chain agent for vinylchloride polymerisation | CIBA-GEIGY AG (CH) | 1983-01-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220212375-A1 | POLYMERIC HOLLOW ARTICLES CONTAINING CHROMAN-BASED COMPOUNDS AND MADE BY ROTATIONAL MOLDING | RPS7, MRPS27, F7 | ESR1 4567/4885GAA 1545/4885KMT2A 3197/4885 |
| US-20220153959-A1 | POLYOLEFIN COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND MOLDED ARTICLES PRODUCED THEREFROM | NOTUM, PMM2, WASF2 | ESR1 4174/4885GAA 905/4885KMT2A 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.